
|Articles|April 15, 2004
Medicare now covers test for monitoring bladder cancer
Medicare groups in all but one state now cover the NMP22 BladderChek Test for both monitoring and diagnosis of bladder cancer, according to the test's manufacturer, Matritech.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
HHS requests testosterone therapy label updates, citing new safety data
2
Unmet needs and emerging solutions in MRI-guided prostate cancer care
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5











